Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-20-002327
Filing Date
2020-02-11
Accepted
2020-02-11 17:31:03
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 dmtp20200211_424b5.htm 424B5 874196
2 dmtp20191219_s3img001.gif GRAPHIC 5243
3 dmtp20200205_424b4img001.gif GRAPHIC 5028
4 g1.jpg GRAPHIC 78661
  Complete submission text file 0001437749-20-002327.txt   998118
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235775 | Film No.: 20598271
SIC: 2834 Pharmaceutical Preparations